AlphaYouCH
Insider selling
Christopher Hite sold $7.3M of Royalty Pharma plc (RPRX) stock
Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 130,000 shares of RPRX stock worth $7.3M, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 2 days before it was made public.
RPRX has moved +4.4% since the trade date, from $56.07 to $58.52 (Sep 22, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 2 days
- Price since
- +4.4%
- Role
- EVP & Chairman, Partnering
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.